Evidence map›Paper›PMID 40014337›Full record

ArticleJAMA oncology2025

Risk of Second Cancer in Erdheim-Chester Disease.

Francesco Pegoraro, Francesco Peyronel, Mohamed-Yassir Errahmani, Francesco Catamerò, Matthias Papo, Fleur Cohen-Aubart, Michelangelo Tesi, Jerome Razanamahery, Frederic Charlotte, Tanguy Le Scornet and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Francesco PegoraroDepartment of Hematology and Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
Francesco PeyronelDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Mohamed-Yassir ErrahmaniDesbres Institute of Epidemiology and Public Health, INSERM, University of Montpellier, Montpellier, France.
Francesco CatameròDepartment of Health Sciences, University of Florence, Florence, Italy.
Matthias PapoInternal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, CIMI INSERM-UMRS 1135, Pitié-Salpȇtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.
Fleur Cohen-AubartInternal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, CIMI INSERM-UMRS 1135, Pitié-Salpȇtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.
Michelangelo TesiNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Jerome RazanamaheryDepartment of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France.
Frederic CharlotteDepartment of Pathology, Pitié-Salpêtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.
Tanguy Le ScornetDepartment of Internal Medicine, Hotel Dieu, Nantes University Hospital, Nantes, France.
Achille AoubaDepartment of Internal Medicine, Caen University Hospital, Caen, France.
Damien Roos-WeilHematology Clinic, Pitié-Salpêtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.
Annalisa TondoDepartment of Hematology and Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
Elena SieniDepartment of Hematology and Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
Zahir AmouraInternal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, CIMI INSERM-UMRS 1135, Pitié-Salpȇtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.
Jean-François EmileEA4340 BECCOH, Pathology Department, Versailles SQY University, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, Boulogne, France.
Isabella Annesi-MaisanoDesbrest Institute of Epidemiology and Public Health, INSERM, University of Montpellier, Montpellier, France.
Augusto VaglioNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Julien HarocheInternal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, CIMI INSERM-UMRS 1135, Pitié-Salpȇtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40014337
PMCPMC11869094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.